Vertex Pharmaceuticals (VRTX) EBT Margin (QoQ) (2009 - 2026)

Vertex Pharmaceuticals (VRTX) EBT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.00
Mar 31, 2026 22.00
Dec 31, 2025 -49.00
Sep 30, 2025 -106.00
Jun 30, 2025 1,691.00
Mar 31, 2025 -1,266.00
Dec 31, 2024 -513.00
Sep 30, 2024 17,234.00
Jun 30, 2024 -17,572.00
Mar 31, 2024 196.00
Dec 31, 2023 -190.00
Sep 30, 2023 89.00
Jun 30, 2023 905.00
Mar 31, 2023 -922.00
Dec 31, 2022 -363.00
Sep 30, 2022 375.00
Jun 30, 2022 112.00
Mar 31, 2022 350.00
Dec 31, 2021 -1,255.00
Sep 30, 2021 5,704.00